Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 9, 2008
Update on the efficacy and tolerability of meropenem in the treatment of serious bacterial infections
John F Mohr
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 23, 2007
Point: Vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus
John F Mohr, Barbara E Murray
Expert Review of Anti-Infective Therapy
|
March 18, 2017
The antibiotic pipeline: reviving research and development and speeding drugs to market
Katherine H Luepke, John F Mohr
Drug Safety
|
March 28, 2008
Dysglycaemias and fluoroquinolones
Roshan J Lewis, John F Mohr
Diagnostic Microbiology and Infectious Disease
|
February 20, 2004
Pharmacokinetic/pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial gram-negative infections in critically ill patients
John F Mohr, Audrey Wanger, John H Rex
The Journal of Antimicrobial Chemotherapy
|
October 15, 2009
Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies
Judith N Steenbergen, John F Mohr, Grace M Thorne
Expert Review of Anti-Infective Therapy
|
September 14, 2017
Intravenous fosfomycin for the treatment of hospitalized patients with serious infections
Andrew F Shorr, Jason M Pogue, John F Mohr
The Journal of Antimicrobial Chemotherapy
|
January 14, 2015
Comment on: Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trials
Michele H Potashman, Danielle N Formella, Kamal Hamed, et al.
International Journal of Antimicrobial Agents
|
February 10, 2009
Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE)
John F Mohr, Lawrence V Friedrich, Sara Yankelev, et al.
Pharmacotherapy
|
October 28, 2009
Antimicrobial susceptibility testing: a primer for clinicians
Kristi M Kuper, Deborah M Boles, John F Mohr, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 9, 2008
Update on the efficacy and tolerability of meropenem in the treatment of serious bacterial infections
John F Mohr
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 23, 2007
Point: Vancomycin is not obsolete for the treatment of infection caused by methicillin-resistant Staphylococcus aureus
John F Mohr, Barbara E Murray
Expert Review of Anti-Infective Therapy
|
March 18, 2017
The antibiotic pipeline: reviving research and development and speeding drugs to market
Katherine H Luepke, John F Mohr
Drug Safety
|
March 28, 2008
Dysglycaemias and fluoroquinolones
Roshan J Lewis, John F Mohr
Diagnostic Microbiology and Infectious Disease
|
February 20, 2004
Pharmacokinetic/pharmacodynamic modeling can help guide targeted antimicrobial therapy for nosocomial gram-negative infections in critically ill patients
John F Mohr, Audrey Wanger, John H Rex
The Journal of Antimicrobial Chemotherapy
|
October 15, 2009
Effects of daptomycin in combination with other antimicrobial agents: a review of in vitro and animal model studies
Judith N Steenbergen, John F Mohr, Grace M Thorne
Expert Review of Anti-Infective Therapy
|
September 14, 2017
Intravenous fosfomycin for the treatment of hospitalized patients with serious infections
Andrew F Shorr, Jason M Pogue, John F Mohr
The Journal of Antimicrobial Chemotherapy
|
January 14, 2015
Comment on: Efficacy and safety of daptomycin for the treatment of infectious disease: a meta-analysis based on randomized controlled trials
Michele H Potashman, Danielle N Formella, Kamal Hamed, et al.
International Journal of Antimicrobial Agents
|
February 10, 2009
Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE)
John F Mohr, Lawrence V Friedrich, Sara Yankelev, et al.
Pharmacotherapy
|
October 28, 2009
Antimicrobial susceptibility testing: a primer for clinicians
Kristi M Kuper, Deborah M Boles, John F Mohr, et al.
Page
of 4